(S)-4-Benzyl-3-(5-bromopentanoyl)oxazolidin-2-one, 98%, 10g

4-Nitro-L-phenylalanine, 97%, 10g

tert-Butyl 3-(chloromethyl)azetidine-1-carboxylate, 95+%, 100mg

4-Chlorophenylurea, 98.0%, 1g

Tapas de cierre, Gesch. frontal, Ø 13 mm 1000 uds.

2-Amino-3-(benzyloxy)propanoic acid, 95.0%, 250mg

EVATANEPAG, 95%, 50mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-acetamide, 95.0%, 5g

4'-Chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-carbaldehyde, 98%, 1g

1-Oxa-7-azaspiro[4.5]Decane hemioxalate, 98%, 1g

3-amino-4'-methoxybiphenyl-4-carboxylic acid, 95.0%, 250mg

2-Ethylbutyraldehyde>98.0%(GC)25mL

2,7-Di-tert-Butylfluorene, 95.0%, 1g